HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Accumulation of somatic mutations in TP53 in gastric epithelium with Helicobacter pylori infection.

AbstractBACKGROUND & AIMS:
Helicobacter pylori infection is a risk factor for gastric cancer. To explore the genetic basis of gastric cancer that develops in inflamed gastric mucosa, we investigated genetic aberrations that latently accumulate in nontumorous gastric epithelium with H pylori infection.
METHODS:
We performed whole-exome sequencing of gastric tumors, noncancerous tissues with gastritis, and peripheral lymphocytes from 5 patients. We performed additional deep-sequencing analyses of selected tumor-related genes using 34 gastritis mucosal samples from patients with or without gastric cancer. We also performed deep sequencing analyses of gastric mucosal tissues from mice that express transgenic human TP53 and constitutively express activation-induced cytidine deaminase (AICDA or AID) (human TP53 knock-in/AID-transgenic mice).
RESULTS:
Whole-exome sequencing revealed that somatic mutations accumulated in various genes in inflamed gastric tissues. Additional deep-sequencing analyses of tissues from regions of gastritis confirmed nonsynonymous low-abundance mutations in TP53 in 15 cases (44.1%) and ARID1A in 5 cases (14.7%). The mutations that accumulated in gastric mucosal tissues with H pylori-induced gastritis, as well as gastric tumors, were predominantly C:G>T:A transitions in GpCpX motifs-a marker of cytidine deamination induced by AID. Constitutive expression of AID in the gastric mucosa of mice led to mutations in the human TP53, at amino acid coding positions identical to those detected in human gastric cancers.
CONCLUSIONS:
Studies of gastric tumors and tissues from humans and mice indicate that somatic mutations accumulate in various genes in gastric mucosal tissues with H pylori infection. Increased cytidine deaminase activity in these tissues appears to promote the accumulation of these mutations and might promote gastric carcinogenesis in patients with H pylori infection.
AuthorsTakahiro Shimizu, Hiroyuki Marusawa, Yuko Matsumoto, Tadashi Inuzuka, Atsuyuki Ikeda, Yosuke Fujii, Sachiko Minamiguchi, Shin'ichi Miyamoto, Tadayuki Kou, Yoshiharu Sakai, Jean E Crabtree, Tsutomu Chiba
JournalGastroenterology (Gastroenterology) Vol. 147 Issue 2 Pg. 407-17.e3 (Aug 2014) ISSN: 1528-0012 [Electronic] United States
PMID24786892 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.
Chemical References
  • ARID1A protein, human
  • DNA-Binding Proteins
  • Nuclear Proteins
  • TP53 protein, human
  • Transcription Factors
  • Tumor Suppressor Protein p53
Topics
  • Animals
  • Cell Transformation, Neoplastic (genetics)
  • DNA Mutational Analysis
  • DNA-Binding Proteins
  • Exome
  • Gastric Mucosa (microbiology)
  • Gastritis (diagnosis, genetics, microbiology)
  • Gene Expression Regulation, Neoplastic
  • Genetic Predisposition to Disease
  • Helicobacter Infections (complications, diagnosis, genetics, microbiology)
  • Helicobacter pylori (pathogenicity)
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Mice
  • Mice, 129 Strain
  • Mice, Transgenic
  • Mutation
  • Nuclear Proteins (genetics)
  • Precancerous Conditions (diagnosis, genetics, microbiology)
  • Risk Factors
  • Stomach Neoplasms (diagnosis, genetics, microbiology)
  • Transcription Factors (genetics)
  • Tumor Suppressor Protein p53 (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: